Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessAXIS Capital Holdings Maintains "Buy" Rating by Cowen & Co.

AXIS Capital Holdings Maintains “Buy” Rating by Cowen & Co.

Add to Favorite
Added to Favorite


Cowen & Co. reaffirms a “Buy” rating for NYSE:AXS, with the stock showing a significant year-to-date increase of 64.7%.
AXIS Capital’s market performance outpaces the industry and sector averages, with a current market capitalization of approximately $7.82 billion.
The company’s stock price has reached a 52-week high, with analysts projecting a potential upside of 8.8%.

On November 27, 2024, Cowen & Co. maintained its “Buy” grade for NYSE:AXS (AXIS Capital Holdings). At the time, the stock was priced at $93.24. AXIS Capital, a company known for its specialty insurance and reinsurance services, has been performing well in the market. It competes with other firms in the finance sector, but its recent performance has been noteworthy.

AXS has experienced a significant rally, with its shares increasing by 64.7% year-to-date. This growth surpasses the industry’s 33.4% rise, the Finance sector’s 23.2% increase, and the Zacks S&P 500 composite’s 25.3% gain. The company’s market capitalization is approximately $7.82 billion, and it has an average trading volume of 0.5 million shares over the past three months.

The company’s success is attributed to its diversified product portfolio, underwriting excellence, digital capabilities, and strong capital position. AXS is trading above its 50-day moving average, indicating a bullish trend, and is near its 52-week high. The stock’s current price is $93.49, reflecting an increase of approximately 2.78%, with a daily rise of $2.53.

Analysts have set an average target price of $96.57 per share for AXS, suggesting a potential upside of 8.8% from the recent closing price. The company’s focus on specialty insurance, reinsurance, and the accident and health portfolio continues to drive its growth. During the trading day, AXS reached a low of $91.53 and a high of $93.74, marking its highest price over the past year.

Subscribe to get Latest News Updates

Latest News

You may like more
more

RH (NYSE: RH) Q3 Fiscal 2024 Earnings Preview

RH is set to release its third-quarter fiscal 2024...

Sportsman’s Warehouse Holdings, Inc. (NASDAQ:SPWH) Surpasses Earnings and Revenue Estimates

Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) reported an EPS of...

Hemogenyx Pharmaceuticals Announces Reverse Stock Split

Hemogenyx Pharmaceuticals PLC (PNK:HOPHF) to undergo a reverse stock...